ClinicalTrials.gov
ClinicalTrials.gov Menu

Cipralex® for Anxiety Disorders in Adolescents (CAP-E)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01293838
Recruitment Status : Unknown
Verified January 2011 by University of Ottawa.
Recruitment status was:  Recruiting
First Posted : February 11, 2011
Last Update Posted : February 11, 2011
Sponsor:
Collaborator:
H. Lundbeck A/S
Information provided by:
University of Ottawa

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2012
  Estimated Study Completion Date : January 2012
Publications:
Silverman, W. K. & Albano, A. M. (1996). The Anxiety Disorders Interview Schedule for DSM-IV—Child and Parent Versions. San Antonio, TX, Psychological Corporation.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-2. San Antonio, TX: Psychological Corporation.
Epstein, M. H., & Sharma, J. M. (2004). Behavioral and Emotional Rating Scale-2: A strength-based approach to assessment. Austin, TX: PRO-ED.
Guy, W. & ECDEU (1976). Assessment Manual for Psychopharmacology. Early Clinical Drug Evaluation Unit.